Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Scheme & Proposed Recapitalisation

17 Mar 2023 07:39

RNS Number : 3475T
Non-Standard Finance PLC
17 March 2023
 

The headline for the Non-Standard Finance PLC announcement released on 17 March 2023 at 07:00 under RNS No 2883T should read Launch of Scheme & Proposed Recapitalisation

The announcement text is unchanged and is reproduced in full below.

 

 

Non-Standard Finance plc

('Non-Standard Finance', 'NSF' or the 'Company')

Launch of scheme of arrangement ('Scheme') and update on proposed recapitalisation

17 March 2023: Non-Standard Finance announces the launch of the Scheme and provides an update on the proposed recapitalisation (the "Proposed Recapitalisation") of the NSF group (the "Group"). The Scheme, if successful, will provide certainty on the extent of the Group's liability for historical redress claims, paving the way for a capital raise which, if successful, would restore the Group's balance sheet, fund the partial payment of redress claims under the Scheme and return Everyday Loans (branch-based lending) to profitable trading.

 

Scheme

Everyday Lending Limited, the wholly owned subsidiary of NSF which runs Everyday Loans and previously ran George Banco and Trust Two until they ceased new lending in November 2020, launches the Scheme today through the issuance of the Practice Statement Letter ("PSL") in relation to the Scheme.

As set out in the PSL, the Scheme will compromise:

subject to certain limited exceptions, claims in relation to any activity which occurred on or before 31 March 2021 in connection with a loan provided by Everyday Loans, George Banco or Trust Two (the "Redress Claims"); and

 

case fees owed to the Financial Ombudsman Service (the "FOS") arising from complaints referred to the FOS on or after 17 March 2023 in relation to any activity which occurred on or before 31 March 2021 in connection with a loan provided by Everyday Loans, George Banco or Trust Two (the "FOS Fees").

 

Under the Scheme, £14 million (the "Scheme Fund") will be made available for payment to customers with valid Redress Claims and the FOS (the "Scheme Creditors"), in exchange for the release of the Redress Claims and the FOS Fees in their entirety. Scheme Creditors are estimated to receive between approximately 22% and 28% recovery.

The Group has negotiated the financial terms of the Scheme with a committee of customers, which decided that it preferred the Scheme over an insolvency process.

 

The FCA has reserved its position on the operation of the Scheme until it has completed its assessment of the proposals. The FCA has only very recently been provided with final details of the Scheme proposals.

 

The FCA has informed the firm that once the terms of the Scheme have been finalised and communicated to it, in the event that the FCA is not satisfied with the Scheme terms, it reserves the right to take any action it may consider appropriate, including to oppose the Scheme in Court.

 

Under the current expected timetable, the Court convening hearing will be held on 28 April 2023, the creditors' meeting where the Scheme Creditors will vote on the Scheme will be held virtually on or around 12 June 2023, and the Court sanction hearing will be held on 22 June 2023. Once sanctioned, the Scheme will be conditional upon the Scheme Fund being funded through the proceeds of the Proposed Recapitalisation or the Alternative Transaction (as defined below).

The Group is now relying on DISP 1.6.2R(2), pursuant to which the business is able to place a temporary hold on the processing of customer complaints included in the Scheme, as it is not in a position to provide a final response to these claims until the conclusion of the Scheme process.

Proposed Recapitalisation

The Scheme is a key component of the Proposed Recapitalisation, which will ensure the future of the Group and the Everyday Loans business. The Group's intention is for the Proposed Recapitalisation to be implemented shortly following Court sanction of the Scheme.

The Proposed Recapitalisation will involve:

NSF raising gross proceeds of approximately £95 million through a public equity raise, part of which will be applied towards the cost of the equity raise and part of which will be used to fund the Scheme Fund and cover the costs of the Scheme, with the remainder being invested in the Everyday Loans business;

 

the Group's secured lenders releasing a portion of their secured debt in exchange for shares in NSF;

 

the extension of the maturity date under the Group's secured debt facilities from August 2023 to June 2027; and

 

the Company and its advisers exploring the cancellation of NSF's listing on the Main Market of the London Stock Exchange plc and its admission of its enlarged share capital to trading on AIM.

 

The Proposed Recapitalisation has the support in principle of NSF's largest shareholder and the Group's secured lenders, subject to agreement on the terms and other conditions described below and, in the case of NSF's largest shareholder, further diligence on and its assessment of the Group's revised business plan and financial projections.

NSF expects the equity raise to include both a placing with new and existing institutional investors as well as an open offer component, whereby existing shareholders will be provided with an opportunity to participate in the capital raise. The structure, detailed terms and viability of the equity raise are expected to be confirmed in Q2 2023 following consultation with major shareholders and potential investors.

Although the Proposed Recapitalisation will ensure the future of the Group and the Everyday Loans business, it will materially dilute the interests of NSF's existing equity holders, most likely to negligible value, unless they choose to participate in the equity raise.

Completion of the Proposed Recapitalisation is subject to the agreement of terms between lenders and the Group's largest shareholder, and a number of conditions, including Court sanction of the Scheme, shareholder approval, the take-up of shares under the equity raise and execution of definitive documents. Assuming all conditions are satisfied, NSF expects the Proposed Recapitalisation to complete at the end of Q2 2023 or the start of Q3 2023.

The Group has also agreed with its secured lenders to implement an alternative transaction if the Scheme is sanctioned but the conditions to the Proposed Recapitalisation are not satisfied (the "Alternative Transaction"). The Alternative Transaction would involve a transfer of the ownership of the Group's business to the secured lenders in exchange for the release of a portion of their secured debt and the provision of a new lending facility. Part of the proceeds from this new lending facility would be used to fund the Scheme Fund and cover the costs of this Scheme. Under the Alternative Transaction, there would be no recovery for the Company's shareholders.

In the event that the Scheme is not sanctioned by the Court, or the Scheme is sanctioned but the Proposed Recapitalisation and Alternative Transaction both fail, then the Group would remain insolvent and the most likely outcome would be a Group-wide insolvency (most likely administration), resulting in no return for current shareholders, a significantly reduced return for secured lenders and minimal or no cash recovery for customers with valid redress claims.

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging the release of this announcement on behalf of Non-Standard Finance plc is Sarah Day, Chief ESG Officer and Group Company Secretary.

Jono Gillespie, Group Chief Executive, said:

"We are very pleased to have reached this important milestone. Whilst this is, in a sense, only the end of the beginning, and significant additional work lies ahead over the coming months, the launch of the Scheme is the first key step in reaching certainty as to the extent of our liability for historical redress claims, which should then lead the way towards a successful recapitalisation of the Group and secure a successful future of our branch-based lending business. It has been a long journey to reach this point and I am thankful to all our stakeholders, including the customer committee, who have helped us get here. I would also like to express my sincere thanks and admiration to all the branch-network team at Everyday Loans who have continued to give 100% throughout this difficult period."

 

For more information:

 

Non-Standard Finance plc

 

Jono Gillespie, Group Chief Executive Officer

 

Sarah Day, Chief ESG Officer and Company Secretary

 

+44 203 869 9020

Cenkos Securities plc 

 

Nicholas Wells

 

Ben Jeynes

 

Callum Davidson

 

+44 207 397 8900

H/Advisors Maitland

 

Neil Bennett

 

Jay Turner

 

+44 207 379 5151

 

+44 7900 000777

 

+44 7867 341385

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJRMRTMTJBMAJ
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.